September 17th 2024
Patients with at least 1 NE-positive marker were shown to have a worsened rPFS and OS.
September 16th 2024
Clinical Challenges Surrounding Treatment Decision-Making in Clinically Localized Prostate Cancer
July 29th 2022A focused discussion on the challenges that urologists commonly face during the treatment decision-making process, and which factors typically inform treatment selection for clinically localized prostate cancer.
Treatment Options for High-Risk, Clinically Localized Prostate Cancer
July 20th 2022Dr Stephen Freedland outlines the currently available, NCCN-recommended treatment options for patients with high-risk, clinically localized prostate cancer, and the clinical challenges he faces during the treatment decision-making process.
For Medicaid-insured patients with cancer, health insurance does not always mean health access
July 19th 2022“We found that Medicaid acceptance differed widely across cancer care facilities," said Michael Leapman, MD, MHS, associate professor of Urology, clinical program leader for the Prostate & Urologic Cancers Program at Yale Cancer Center and Smilow Cancer Hospital.